TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.15, no.4, pp.217-221, 2018 (ESCI)
Objective: To evaluate clinical pregnancy rates, miscarriage rates, ongoing pregnancy rates, and in vitro fertilization-intra cytoplasmic sperm injection outcomes of gonadotropin releasing hormone agonist (GriRHa) administration compared with human chorionic gonadotropin (hCG) application for luteal phase support.